Summary
Overview
Work History
Education
Skills
Personal Information
Awards
Publications
Timeline
Generic
Tan Lu Wen Shawn

Tan Lu Wen Shawn

Senior Scientist (Oncology)

Summary

Cancer biologist with a PhD from the University of Cambridge, specializing in the connections between cellular metabolism and cancer pathogenesis. Currently a postdoctoral researcher at A*STAR, Singapore, investigating how obesity contributes to non-alcoholic steatohepatitis and hepatocellular carcinoma in the liver. Extensive experience in diet-induced obesity mouse models, in vitro cellular models, bioinformatics skills, integrative multi-omic data analysis.

Overview

13
13
years of professional experience
7
7
years of post-secondary education

Work History

Senior Scientist

Institute of Molecular & Cell Biology, A*STAR
4 2022 - Current

Research Fellow

Institute of Molecular & Cell Biology, A*STAR
11.2018 - 03.2022
  • Project lead in molecular mechanisms underpinning the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma (HCC) using mouse models of diet-induced obesity. Extensive experience in obesity mouse models, liver cancer biology, bioinformatics analysis.

Post-doctoral Research Associate

Medical Research Council Cancer Unit, University of Cambridge
10.2016 - 09.2018
  • Developing new therapeutic strategies that exploit tumour aldehyde metabolism to selectively kill BRCA2-deficient cancer cells. The work entails the use of metabolomics and genetic techniques such as CRISPR knockout screens.

PhD in Oncology

Medical Research Council Cancer Unit, University of Cambridge
10.2012 - 09.2016
  • Identified the susceptibility of the BRCA2 tumour suppressor to aldehyde-induced proteolysis. Culminated in a publication in Cell in 2017. Knowledge in the field of the DNA damage response in cancer.

Research Assistant

Institute of Molecular and Cell Biology, A*STAR
08.2011 - 08.2012
  • Studied the role of Cdk2 and Cyclin A2 in carcinogenesis using genetic knockout mouse models.

Education

Ph.D. - Oncology

University of Cambridge
United Kingdom
10.2012 - 07.2017

Bachelor of Science - Biochemistry (First Class Honours)

Imperial College London
United Kingdom
10.2008 - 07.2011

Skills

Project Lead

Scientific Writing

Critical Thinking

Training and mentoring

Mouse models and genetics

Bioinformatics analysis

RNA-sequencing

Single-cell transcriptomics

Metabolomics Data Analysis

Cell Culture Assays & Techniques

Cell line generation (CRISPR/Cas9, lentivirus)

Molecular biology (WB, IF, IHC, ELISA, qRT-PCR)

Microscopy

Molecular cloning

Cancer xenograft models

Personal Information

  • Date of Birth: 06/17/87
  • Nationality: Singaporean

Awards

  • 2008, National Science Scholarship (BS), Agency of Science, Technology and Research, Singapore
  • 2010, 2010 Wiley Prize for Outstanding Performance by a Student in the 2nd year of the Biochemistry or Biotechnology degree course
  • 2011, Beloff-Chain Award for Outstanding Performance in the Biochemistry or Biotechnology degree course
  • 2012, National Science Scholarship (PhD), Agency of Science, Technology and Research, Singapore
  • 2021, Open-Fund Young Individual Research Grant, S$300,000, 3 years, Lead PI, Investigating the role of lipid peroxidation as an instigator of genomic instability in the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma.
  • 2024, IMCB Discovery Catalyst Grant, S$190,000, 1 year, Co-I, Neural Regulation of Liver Cancer

Publications

  • Kong LR, Gupta K, ... Tan SLW, ... Venkitaraman AR, A glycolytic metabolite bypasses 'two-hit' tumor suppression by BRCA2, Cell, 04/25/24, 187, 9, 2269-2287.e16
  • Tan SLW, Tan HM, Israeli E, et al., Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity, Biochem J, 2023, 480, 24, 2045-2058
  • Tan SLW, Israeli E., Ericksen R.E., Chow P.K.H., Han W., The altered lipidome of hepatocellular carcinoma, Seminars in Cancer Biology, 2022, 86, 445-456
  • Tan SLW, Chadha S., Liu Y., Gabasova E., Perera D., Ahmed K., Constantinou S., Renaudin X., Lee M., Aebersold R., Venkitaraman AR., A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability, Cell, 2017, 169, 1105-1118
  • Gopinathan L., Tan SLW., Padmakumar V.C., Coppola V., Tessarollo L., Kaldis P., Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis, Cancer Research, 2014, 74, 14, 3870-3879

Timeline

Research Fellow

Institute of Molecular & Cell Biology, A*STAR
11.2018 - 03.2022

Post-doctoral Research Associate

Medical Research Council Cancer Unit, University of Cambridge
10.2016 - 09.2018

Ph.D. - Oncology

University of Cambridge
10.2012 - 07.2017

PhD in Oncology

Medical Research Council Cancer Unit, University of Cambridge
10.2012 - 09.2016

Research Assistant

Institute of Molecular and Cell Biology, A*STAR
08.2011 - 08.2012

Bachelor of Science - Biochemistry (First Class Honours)

Imperial College London
10.2008 - 07.2011

Senior Scientist

Institute of Molecular & Cell Biology, A*STAR
4 2022 - Current
Tan Lu Wen ShawnSenior Scientist (Oncology)